OGN vs PH · P/E 3.4, rev $6.40B vs P/E 28, rev $19.85B
Organon & Co (OGN) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the OGN and PH stock pages for the full models.
Not investment advice.